The Journal of Experimental Medicine · 1997 · 106 citations · 58 references
Life SciencesMicrobiologyMolecular BiologyAntimicrobial ResistanceInnate ImmunityMicrobial MetabolismAntibacterial ResistanceBacterial MetabolismMacrophage BiologyPulmonary TuberculosisReactive Nitrogen Species BiologyReactive Oxygen SpeciesAntioxidant InhibitionAntioxidant MetabolismEscherichia ColiMacrophage Reactive Oxygen Species ResponsesMycobacterium Tuberculosis InfectionMycobacterium Tuberculosis PathogenesisNitrite RemovalReactive Nitrogen Species Production
Among the major antimicrobial products of macrophages are reactive intermediates of the oxidation of nitrogen (RNI) and the reduction of oxygen (ROI). Selection of recombinants in acidified nitrite led to the cloning of a novel gene, noxR1, from a pathogenic clinical isolate of Mycobacterium tuberculosis. Expression of noxR1 conferred upon Escherichia coli and Mycobacterium smegmatis enhanced ability to resist RNI and ROI, whether the bacteria were exposed to exogenous compounds in medium or to endogenous products in macrophages. These studies provide the first identification of an RNI resistance mechanism in mycobacteria, point to a new mechanism for resistance to ROI, and raise the possibility that inhibition of the noxR1 pathway might enhance the ability of macrophages to control tuberculosis.
58
Aihao Ding, Carl Nathan, Dennis J. Stuehr · The Journal of Immunology · 1988 · 2.8K citations · Full text
Carl Nathan, Henry W. Murray, Michael E. Wiebe et al. · The Journal of Experimental Medicine · 1983 · 2K citations · Full text
John D. MacMicking, Carl Nathan, Gary Hom et al. · Cell · 1995 · 1.4K citations · Full text